Cargando…
Managing Device‐Aided Treatments in Parkinson's Disease in Times of COVID‐19
Autores principales: | Abate, Filomena, Erro, Roberto, Barone, Paolo, Picillo, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276832/ https://www.ncbi.nlm.nih.gov/pubmed/32775535 http://dx.doi.org/10.1002/mdc3.12985 |
Ejemplares similares
-
Impact of COVID-19 on neurological patients attending a botulinum toxin service
por: Erro, Roberto, et al.
Publicado: (2020) -
Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic
por: Erro, Roberto, et al.
Publicado: (2022) -
Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease
por: Landolfi, Annamaria, et al.
Publicado: (2022) -
Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsy
por: Cuoco, Sofia, et al.
Publicado: (2021) -
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease
por: Picillo, Marina, et al.
Publicado: (2020)